17-44354620-C-G
Variant summary
Our verdict is Uncertain significance. Variant got 1 ACMG points: 2P and 1B. PM2BP4
The NM_198475.3(FAM171A2):āc.1594G>Cā(p.Val532Leu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000731 in 1,272,204 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 12/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_198475.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 1 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
FAM171A2 | NM_198475.3 | c.1594G>C | p.Val532Leu | missense_variant | 8/8 | ENST00000293443.12 | NP_940877.2 | |
FAM171A2 | XM_017024490.2 | c.1042G>C | p.Val348Leu | missense_variant | 6/6 | XP_016879979.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
FAM171A2 | ENST00000293443.12 | c.1594G>C | p.Val532Leu | missense_variant | 8/8 | 1 | NM_198475.3 | ENSP00000293443.6 |
Frequencies
GnomAD3 genomes AF: 0.0000994 AC: 15AN: 150840Hom.: 0 Cov.: 32
GnomAD4 exome AF: 0.0000696 AC: 78AN: 1121256Hom.: 0 Cov.: 31 AF XY: 0.0000801 AC XY: 43AN XY: 537058
GnomAD4 genome AF: 0.0000994 AC: 15AN: 150948Hom.: 0 Cov.: 32 AF XY: 0.000122 AC XY: 9AN XY: 73794
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jun 12, 2023 | The c.1594G>C (p.V532L) alteration is located in exon 8 (coding exon 8) of the FAM171A2 gene. This alteration results from a G to C substitution at nucleotide position 1594, causing the valine (V) at amino acid position 532 to be replaced by a leucine (L). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at